BioNTech, a German based biotech company, and Pfizer, the well-established pharmaceutical company headquartered in the United States, have partnered to produce one of the 17 COVID-19 vaccines currently in development. The vaccine has shown promising early-stage human trials among 24 participants, alongside other pharmaceutical companies like Moderna, Inovio Pharmaceuticals, and CanSino Biologics. BioNTech’s co-founder and Chief Executive Officer Ugur Sahin said, “These first trial results show that the vaccine yields immune activity and causes a strong immune response.” 

Read more here

More on: